<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Screening and early diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e>, major health problem in industrialised countries, fulfils the conditions required for mass screening </plain></SENT>
<SENT sid="1" pm="."><plain>Data from controlled studies indicate that it is possible to reduce <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> mortality at a population level using faecal occult blood testing </plain></SENT>
<SENT sid="2" pm="."><plain>Population-based studies rely on biennial testing in subjects between 50 and 74 and total colonoscopy in case of positive test </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> mortality decrease in this case varies between 15 and 28% in the general population, 33 and 39% among participants to screening </plain></SENT>
<SENT sid="4" pm="."><plain>In order to decrease significantly <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> mortality compliance has to be over 50% </plain></SENT>
<SENT sid="5" pm="."><plain>On the basis of available data, the European Commission recommended to organise <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> screening in the EU </plain></SENT>
<SENT sid="6" pm="."><plain>Epidemiological studies allow us to define subjects at high risk for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Colonoscopy screening is recommended in first degree relatives of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> diagnosed before 60 or 65 or with two affected first-degree relatives, in subjects with an extended <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> or <z:e sem="disease" ids="C0010346" disease_type="Disease or Syndrome" abbrv="">Crohn disease</z:e> or with a personal history of <z:e sem="disease" ids="C0009402" disease_type="Neoplastic Process" abbrv="CRC">large bowel cancer</z:e> or large <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
</text></document>